Inventor
DARWISH IHAB
US32 patents
⚠️ This page may combine multiple inventors who share the name “DARWISH IHAB”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RIGEL PHARMACEUTICALS INC
28 patentsUS10975064B2Apr 13, 2021
RIP1 inhibitory compounds and methods for making and using the same
RIGEL PHARMACEUTICALS INC14 citations86
US11407736B2Aug 9, 2022
RIP1 inhibitory compounds and methods for making and using the same
RIGEL PHARMACEUTICALS INC4 citations84
US9475781B2Oct 25, 2016
Fumarate analogs and uses thereof
RIGEL PHARMACEUTICALS INC11 citations84
US11584758B2Feb 21, 2023
RIP1K inhibitors
RIGEL PHARMACEUTICALS INC5 citations73
US11110082B2Sep 7, 2021
Tyrosine kinase inhibitors
RIGEL PHARMACEUTICALS INC2 citations73
US10822337B2Nov 3, 2020
TGF-β inhibitorC
RIGEL PHARMACEUTICALS INC4 citations73
US10434096B2Oct 8, 2019
Tyrosine kinase inhibitors
RIGEL PHARMACEUTICALS INC2 citations73
US10130623B2Nov 20, 2018
Tyrosine kinase inhibitors
RIGEL PHARMACEUTICALS INC2 citations73
US9801866B2Oct 31, 2017
Fumarate analogs and uses thereof
RIGEL PHARMACEUTICALS INC3 citations73
US11370787B2Jun 28, 2022
Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulations
RIGEL PHARMACEUTICALS INC4 citations71
US11919890B2Mar 5, 2024
RIP1 inhibitory compounds and methods for making and using the same
RIGEL PHARMACEUTICALS INC1 citations63
US12297202B2May 13, 2025
RIP1K inhibitors
RIGEL PHARMACEUTICALS INC0 citations62
US12227508B2Feb 18, 2025
TGF-β inhibitors
RIGEL PHARMACEUTICALS INC0 citations62
US11672791B2Jun 13, 2023
Tyrosine kinase inhibitors
RIGEL PHARMACEUTICALS INC0 citations62
US11667643B2Jun 6, 2023
RIP1K inhibitors
RIGEL PHARMACEUTICALS INC0 citations62
US11466018B2Oct 11, 2022
TGF-β inhibitors
RIGEL PHARMACEUTICALS INC0 citations62
US11129819B2Sep 28, 2021
Fumarate analogs and uses thereof
RIGEL PHARMACEUTICALS INC0 citations62
US12043629B2Jul 23, 2024
RIP1K inhibitors
RIGEL PHARMACEUTICALS INC0 citations61
US12357623B2Jul 15, 2025
Method for treating a disease or condition using a pyrazole compound or formulation thereof
RIGEL PHARMACEUTICALS INC0 citations60
US7776847B2Aug 17, 2010
Benzisothiazoles useful for treating or preventing HCV infection
RIGEL PHARMACEUTICALS INC3 citations59
US10889562B2Jan 12, 2021
Prodrugs of Nrf2 activating compounds and uses thereof
RIGEL PHARMACEUTICALS INC0 citations56
US11578078B2Feb 14, 2023
Heterocyclic RIP1 inhibitory compounds
RIGEL PHARMACEUTICALS INC0 citations52
US11564930B2Jan 31, 2023
RIP1 inhibitory compounds and methods for making and using the same
RIGEL PHARMACEUTICALS INC0 citations52
US10493066B2Dec 3, 2019
Fumarate analogs and uses thereof
RIGEL PHARMACEUTICALS INC0 citations52
US9624229B2Apr 18, 2017
Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases
RIGEL PHARMACEUTICALS INC0 citations52
US12459941B2Nov 4, 2025
Tricyclic IRAK inhibitors
RIGEL PHARMACEUTICALS INC0 citations47
US10774066B2Sep 15, 2020
Prodrugs of NRF2 activating compounds and uses thereof
RIGEL PHARMACEUTICALS INC0 citations45
US10851093B2Dec 1, 2020
Tyrosine kinase inhibitors
RIGEL PHARMACEUTICALS INC0 citations42